Relation of oral 1α-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients

Heart and Vessels

Volumn 25, Issue 1, 2010, Pages 7-13

  Ogawa, Tetsuya ^a   Ishida, Hideki ^b   Akamatsu, Mayuko ^a   Matsuda, Nami ^a   Fujiu, Ayuko ^a   Ito, Kyoko ^b   Ando, Yoshitaka ^b   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Hidaka Hospital   (Japan)

Author keywords

Aortic arch calcification; Cardiovascular disease; Chest radiography; Hemodialysis; Vitamin d

Indexed keywords

ALBUMIN; ALFACALCIDOL; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY; TREATMENT DURATION;

EID: 77951771924     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1156-z     Document Type: Article

References (34)

1. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ (2005) Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998-1999. J Am Soc Nephrol 16: 489-495 (Pubitemid 41725146)
2. Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, NavesDiaz M, Diaz-Lopez B (2006) Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17(12 suppl 3):S267-S273 (Pubitemid 44865260)
3. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701
4. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM (2000) Phosphate regulations of vascular smooth muscle cell calcification. Circ Res 87:E10-E17
5. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38(4 suppl 1):S34-S37
6. Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021 (Pubitemid 30410374)
7. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM (1998) Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535-541 (Pubitemid 28177892)
8. Pan N-H, Yang H-Y, Hsieh M-H, Chen Y-J (2008) Coronary calcium score from multislice computed tomography correlates with QT dispersion and left ventricular wall thickness. Heart Vessels 23:155-160
9. Raine AE, Bedford L, Simpson AW, Ashley CC, Brown R, Woodhead JS, Ledingham JG (1993) Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 43:700-705 (Pubitemid 23071955)
10. 3 on cell-mediated immunity in hemodialyzed patients. J Clin Endocrinol Metab 63:1218-1221
11. Ribeiro S, Ramos A, Brandao A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remedio F, Ribeiro F (1998) Cardiac valve calcification in haemodialysis patients: role of calciumphosphate metabolism. Nephrol Dial Transplant 13:2037-2040 (Pubitemid 28356772)
12. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446-456 (Pubitemid 36910023)
13. Ogawa T, Ishida H, Matsuda N, Fujiu A, Matsuda A, Ito K, Ando Y, Nitta K (2009) Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int (in press)
14. Iribarren C, Sidney S, Sternfeld B, Browner WS (2000) Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 283:2810-2815 (Pubitemid 30387825)
15. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N; Vascular Calcification Work Group (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572-579
16. Witteman JC, Kannel WB, Wolf PA, Grobbee DE, Hofman A, D'Agostino RB, Cobb JC (1990) Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 66:1060-1064 (Pubitemid 20365357)
17. Witteman JC, Kok FJ, van Saase JL, Valkenburg HA (1986) Aortic calcification as a predictor of cardiovascular mortality. Lancet 2:1120-1122
18. Li J, Galvin HK, Johnson SC, Langston CS, Sclamberg J, Preston CA (2002) Aortic calcification on plain chest radiography increases risk for coronary artery disease. Chest 121:1468-1471 (Pubitemid 34499657)
19. Salgueira M, del Toro N, Moreno-Alba (2003) Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int 63 (Suppl 85):S119-S121
20. Lemmila S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A (1998) Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 18:404-410 (Pubitemid 28442103)
21. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK (1999) Intravenous calcitriol regress myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33:73-81 (Pubitemid 29031211)
22. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E (2006) Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 21:484-490 (Pubitemid 43306570)
23. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D (2005) 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sesipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 20:1370-1377 (Pubitemid 41430610)
24. Teng M, Wolf M, Ofsthum MN, Lazarus MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115-1125 (Pubitemid 41710323)
25. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 270:1858-1865 (Pubitemid 44684819)
26. Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA (2006) Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 318:90-98 (Pubitemid 43920745)
27. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771-780 (Pubitemid 44215354)
28. Cardus A, Panizo S, Parisi E, Fernandez E, Valdivielso JM (2007) Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 22:860-866 (Pubitemid 351339746)
29. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis patients. Nephrol Dial Transplant 19:179-184. (Pubitemid 38072630)
30. Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, NavesDiaz M, Diaz-Lopez B (2006) Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17:S267-S273 (Pubitemid 44865260)
31. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metvier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613-620 (Pubitemid 46193327)
32. Spiegel DM, Raggi P, Smits G, Block GA (2007) Factors associated with mortality in patients new to haemodilaysis. Nephrol Dial Transplant 22:3568-3572 (Pubitemid 350212490)
33. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G; Kidney Disease: Improving Global Outcomes (KDIGO) (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953
34. National Kidney Foundation (2003) KDOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (Suppl 3):1-201